Although shortages of brand-name GLP-1 therapies, such as Novo Nordisks semaglutide products Ozempic and Wegovy and Eli Lillys tirzepatide offerings Zepbound and Mounjaro, have officially been resolved, some telehealth firms, including Hims & Hers, have continued offering compounded versions
As more doses of branded GLP-1 drugs become available, the future of compounded versions remains uncertain
It is the first triple-hormone-receptor agonist to reach advanced clinical trials, activating three distinct metabolic pathways that individually would each justify their own drug development program
Three Major Trends Reshaping the CPG Landscape This nutrition revolution is driven by three interconnected trends that are changing how consumers make food decisions
R., Wefers, J
There is no promotional first-month introductory rate that spikes at the first refill a pricing structure that has generated significant patient confusion at several competing platforms in the current market